Navigation Links
OncoSec Medical Announces $7.2 Million Public Offering
Date:12/13/2012

rrent preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in OncoSec Medical's filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward looking statements which speak only as of the date they are made. OncoSec Medical disclaims any obligation to update any forward looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015  PAREXEL International Corporation ... be presenting at the Goldman Sachs Healthcare Conference in ... and Chief Executive Officer, will be making a presentation ... PDT on Tuesday, June 9, 2015. A ... the "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
(Date:5/26/2015)...  OrthoAccel ® Technologies, Inc., the leader in non-invasive, ... in response to continued demand from orthodontists and patients ... 2,500 practice locations in the U.S. and ... is the only FDA-cleared Class II medical device ... by as much as 50 percent.  ...
(Date:5/26/2015)... , May 26, 2015  Halyard Health, Inc. (NYSE: ... and chief executive officer will present at the 2015 Morgan ... at approximately 8:45 a.m., CDT on Thursday, June 4. ... available in the Investors section of the Halyard Health website ... site. About Halyard Health: Halyard ...
Breaking Medicine Technology:PAREXEL International To Present At Goldman Sachs Healthcare Conference 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3
... Targetbase , a leading ... understanding consumer data, translating that data into intelligence, and ... today announced that Peter Dannenfelser has joined the agency ... pharmaceutical marketing executive with extensive experience at healthcare companies ...
... Inc. is changing its name to Xeridiem Medical Devices, ... "Although we,re changing our name, we will continue ... development, and manufacturing services that we,ve provided for nearly ... President. "Our mission remains the same - to improve healthcare ...
Cached Medicine Technology:Peter Dannenfelser Joins Targetbase as Vice President of Strategy, Bringing 15 Years of Pharmaceutical Marketing Experience 2Peter Dannenfelser Joins Targetbase as Vice President of Strategy, Bringing 15 Years of Pharmaceutical Marketing Experience 3MRI Medical Inc. Changing Name to Xeridiem Medical Devices, Inc. 2
(Date:5/27/2015)... 2015 Water, Inc. , ... products, has announced that its elite BG-12000 Body ... first to pass the new NSF/ANSI Standard 401 ... monumental, proving that the BG-12000 by Water, Inc. ... medications, and chemicals used in manufacturing that are ...
(Date:5/27/2015)... May 27, 2015 This year, Mental ... awareness campaign and encouraging those affected to seek assistance before ... Health (NAMI), one in five children, ages 13 to ... Additionally, 50% of all cases of mental illness within one's ... it is essential to seek help before reaching a critical ...
(Date:5/27/2015)... Palm Springs, CA (PRWEB) May 27, 2015 ... public health campaign dedicated to ending the spread of ... digital advocates at the 1st Annual YesGTCV Social Ambassador ... from 6 – 7 p.m. PST. , A first ... reward Get Tested Coachella Valley’s most active online influencers ...
(Date:5/27/2015)... Kudolife , a free diet and ... release available at the App Store today. This ... calories and activities with a glance by utilizing machine ... for accurate tracking. , The complete lifestyle iOS app ... which will allow users to proactively stay on track ...
(Date:5/27/2015)... One of America's most cherished actors, James ... America” that takes a look at the topic of ... an abnormal heart rhythm. Those who suffer from atrial ... much too quickly. , This new segment will take ... effort to inform viewers about possible signs that commonly ...
Breaking Medicine News(10 mins):Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 2Health News:Water, Inc.’s BG-12000 Body Glove Water Filter System Receives NSF/ANSI Standard 401 Certification for Pharmaceutical Emerging Contaminant Reduction 3Health News:The Glenholme School Observes Mental Health Awareness Month 2Health News:The Glenholme School Observes Mental Health Awareness Month 3Health News:Regional Public Health Campaign to Host 1st Annual YesGTCV Social Ambassador Awards 2Health News:Regional Public Health Campaign to Host 1st Annual YesGTCV Social Ambassador Awards 3Health News:Kudolife Launches into Apple Watch App Market with Newest Release 2Health News:Kudolife Launches into Apple Watch App Market with Newest Release 3
... experts say , , FRIDAY, Sept. 28 (HealthDay News) -- ... autoimmune disease lupus is building up steam, a group ... researchers from across the United States spoke at a ... of the improving outlook for patients with systemic lupus ...
... of,Labor,s Occupational Safety and Health Administration (OSHA) today ... Grants to 55 nonprofit,organizations for safety and health ... are at the heart of our compliance assistance,efforts ... Labor for,OSHA Edwin G. Foulke Jr. "The Harwood ...
... Association (PCMA) released the following statement today,supporting legislation ... Energy and Commerce Subcommittee on Health: "PCMA ... week that would fix the flawed Average Manufacturer ... Act. "PCMA supports the decision to remove ...
... Laboratories Inc.,(NYSE: MYL ) ("Mylan") announced today that ... previously announced cash tender offers and consent,solicitations for its ... Notes") and 6.375% Senior Notes due 2015 (CUSIP Nos. ... Notes, the,"Notes"), which are being conducted pursuant to the ...
... is giving a,keynote address or visiting on the sidewalk ... possibility. "Only in America could someone like me ... laugh, "I,m a physically disabled woman whose,father is a ... I,m running for Town Council as a Republican." ...
... September 28, 2007 - Oncolytics Biotech Inc. (Oncolytics) ... interim results from a U.K. Phase Ia/Ib ... with advanced or metastatic cancers is scheduled to ... (NCRI) conference on October 2, 2007 in Birmingham, ...
Cached Medicine News:Health News:Better Lupus Treatments on the Horizon 2Health News:Better Lupus Treatments on the Horizon 3Health News:Better Lupus Treatments on the Horizon 4Health News:U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants 2Health News:Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015 2Health News:Humor and Hope Sustain NJ Woman Through Disabling Movement Disorder, Election Campaign 2Health News:Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials 2Health News:Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: